Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo (NCT05801679) | Clinical Trial Compass
CompletedPhase 3
Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo
United States74 participantsStarted 2023-07-03
Plain-language summary
This is a prospective randomized blinded controlled trial that will enroll 175 subjects undergoing cardiopulmonary bypass at NorthShore University HealthSystem. The purpose of this study is to compare clinical outcomes in elective and urgent cardiac surgical patients at NorthShore University HealthSystem when receiving sugammadex, a common neuromuscular blockade reversal drug given after surgery and before the breathing tube is removed vs. those patients who do not receive sugammadex (placebo) group. The Investigators will compare the following outcomes in both the sugammadex and placebo groups during patients hospital stay: # of patients who have the breathing tube removed within 6 hour of the end of surgery, time it takes to remove the breathing tube after surgery, ICU and hospital length of stay, cost of the ICU stay, time to achieve a train of four ratio of \> or equal to 0.9, whether patients develop pneumonia or not, whether they require the breathing tube to be replaced during their hospital stay and to compare the nursing perception of patients recovery within first 24 hours of their ICU stay.
Who can participate
Age range21 Years – 90 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Subject must be an elective or urgent cardiac surgical patient undergoing cardiopulmonary bypass at NorthShore University HealthSystem.
✓. Male or female subject aged 21 to 90 years, at the time of consent.
✓. Subject who can consent in English.
✓. Subjects who are eligible for fast track extubation as defined by those patients who plan on being extubated within 24 hours of the end of surgery and optimally within the 6-hour STS benchmark time from end of surgery.
Exclusion criteria
✕. Subjects having emergency cardiac surgery.
✕. Subjects who cannot consent in English.
✕. Subjects who are not eligible to be extubated within 24 hours of the end of surgery.
✕. Subjects with neuromuscular disorders.
✕. Subjects on home oxygen.
✕
What they're measuring
1
Society of Thoracic Surgery (STS) Quality Benchmark of Early Extubation Criteria